{
    "domain": "medicine",
    "concept": "approved drug for lung cancer",
    "definition": "A drug approved to treat lung cancer",
    "selection_criteria": [
        "it is a drug",
        "it has been approved to treat lung cancer"
    ],
    "referents_source": "https://www.cancer.gov/about-cancer/treatment/drugs/lung",
    "referents": [
        "Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)",
        "Adagrasib",
        "Afatinib Dimaleate",
        "Afinitor (Everolimus)",
        "Afinitor Disperz (Everolimus)",
        "Alecensa (Alectinib)",
        "Alectinib",
        "Alimta (Pemetrexed Disodium)",
        "Alunbrig (Brigatinib)",
        "Alymsys (Bevacizumab)",
        "Amivantamab-vmjw",
        "Atezolizumab",
        "Atezolizumab and Hyaluronidase-tqjs",
        "Augtyro (Repotrectinib)",
        "Avastin (Bevacizumab)",
        "Bevacizumab",
        "Binimetinib",
        "Bizengri (Zenocutuzumab-zbco)",
        "Braftovi (Encorafenib)",
        "Brigatinib",
        "Capmatinib Hydrochloride",
        "Cemiplimab-rwlc",
        "Ceritinib",
        "Crizotinib",
        "Cyramza (Ramucirumab)",
        "Dabrafenib Mesylate",
        "Dacomitinib",
        "Docetaxel",
        "Doxorubicin Hydrochloride",
        "Durvalumab",
        "Encorafenib",
        "Enhertu (Fam-Trastuzumab Deruxtecan-nxki)",
        "Ensacove (Ensartinib Hydrochloride)",
        "Ensartinib Hydrochloride",
        "Entrectinib",
        "Erlotinib Hydrochloride",
        "Everolimus",
        "Fam-Trastuzumab Deruxtecan-nxki",
        "Gavreto (Pralsetinib)",
        "Gefitinib",
        "Gilotrif (Afatinib Dimaleate)",
        "Gemcitabine Hydrochloride",
        "Gemzar (Gemcitabine Hydrochloride)",
        "Imfinzi (Durvalumab)",
        "Imjudo (Tremelimumab-actl)",
        "Infugem (Gemcitabine Hydrochloride)",
        "Ipilimumab",
        "Iressa (Gefitinib)",
        "Keytruda (Pembrolizumab)",
        "Krazati (Adagrasib)",
        "Lazcluze (Lazertinib Mesylate Hydrate)",
        "Lazertinib Mesylate Hydrate",
        "Libtayo (Cemiplimab-rwlc)",
        "Lorbrena (Lorlatinib)",
        "Lorlatinib",
        "Lumakras (Sotorasib)",
        "Mekinist (Trametinib Dimethyl Sulfoxide)",
        "Mektovi (Binimetinib)",
        "Methotrexate Sodium",
        "Mvasi (Bevacizumab)",
        "Necitumumab",
        "Nivolumab",
        "Nivolumab and Hyaluronidase-nvhy",
        "Opdivo (Nivolumab)",
        "Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)",
        "Osimertinib Mesylate",
        "Paclitaxel",
        "Paclitaxel Albumin-stabilized Nanoparticle Formulation",
        "Pembrolizumab",
        "Pemetrexed Disodium",
        "Portrazza (Necitumumab)",
        "Pralsetinib",
        "Ramucirumab",
        "Repotrectinib",
        "Retevmo (Selpercatinib)",
        "Rozlytrek (Entrectinib)",
        "Rybrevant (Amivantamab-vmjw)",
        "Selpercatinib",
        "Sotorasib",
        "Tabrecta (Capmatinib Hydrochloride)",
        "Tafinlar (Dabrafenib Mesylate)",
        "Tagrisso (Osimertinib Mesylate)",
        "Tarceva (Erlotinib Hydrochloride)",
        "Taxotere (Docetaxel)",
        "Tecentriq (Atezolizumab)",
        "Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)",
        "Tepmetko (Tepotinib Hydrochloride)",
        "Tepotinib Hydrochloride",
        "Trametinib Dimethyl Sulfoxide",
        "Tremelimumab-actl",
        "Vizimpro (Dacomitinib)",
        "Vinorelbine Tartrate",
        "Xalkori (Crizotinib)",
        "Yervoy (Ipilimumab)",
        "Zenocutuzumab-zbco",
        "Zirabev (Bevacizumab)",
        "Zykadia (Ceritinib)",
        "Afinitor (Everolimus)",
        "Atezolizumab",
        "Atezolizumab and Hyaluronidase-tqjs",
        "Doxorubicin Hydrochloride",
        "Durvalumab",
        "Etopophos (Etoposide Phosphate)",
        "Etoposide",
        "Etoposide Phosphate",
        "Everolimus",
        "Hycamtin (Topotecan Hydrochloride)",
        "Imdelltra (Tarlatamab-dlle)",
        "Imfinzi (Durvalumab)",
        "Lurbinectedin",
        "Methotrexate Sodium",
        "Nivolumab",
        "Opdivo (Nivolumab)",
        "Tarlatamab-dlle",
        "Tecentriq (Atezolizumab)",
        "Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)",
        "Topotecan Hydrochloride",
        "Zepzelca (Lurbinectedin)"
    ] 
}